Barclays
BTX.WS

Barclays’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Barclays’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,151
Closed – – 7634
2018
Q2 		$0 Hold
1,151
– – ﹤0.01% 7546
2018
Q1 		$0 Sell
1,151
-115
-9% -$17 ﹤0.01% 7555
2017
Q4 		$0 Sell
1,266
-8
-0.6% -$1 ﹤0.01% 7281
2017
Q3 		$0 Hold
1,274
– – ﹤0.01% 7217
2017
Q2 		$0 Sell
1,274
-2
-0.2% -$1 ﹤0.01% 7145
2017
Q1 		$0 Hold
1,276
– – ﹤0.01% 7140
2016
Q4 		$1K Hold
1,276
– – ﹤0.01% 6545
2016
Q3 		$1K Sell
1,276
-89
-7% -$45 ﹤0.01% 6528
2016
Q2 		$0 Hold
1,365
– – ﹤0.01% 6827
2016
Q1 		$0 Sell
1,365
-728
-35% -$492 ﹤0.01% 6634
2015
Q4 		$2K Hold
2,093
– – ﹤0.01% 5786
2015
Q3 		$0 Hold
2,093
– – ﹤0.01% 7200
2015
Q2 		$2K Hold
2,093
– – ﹤0.01% 6864
2015
Q1 		$4K Sell
2,093
-332
-14% -$445 ﹤0.01% 6732
2014
Q4 		$2K Buy
+2,425
New +$2.63K ﹤0.01% 7148

Barclays's BTX.WS Position: Q3 2018 in Review

Barclays sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2018, closing a stake of 1,151 shares.

Barclays first reported a position in BTX.WS in Q4 2014 and held it in 15 quarters. The position peaked at $4K in Q1 2015. 7 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2018.

  • Barclays reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2018 after selling out during the quarter.
  • Barclays sold 1,151 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2018.
  • Barclays first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 15 quarters.
  • Barclays's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $4K in Q1 2015.
  • 7 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2018.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.